Dernière mise à jour :
18/03/2024
Etudes de stabilité souhaitées par les utilisateurs de Stabilis : 65  
Recherchez les études souhaitées par les utilisateurs de Stabilis en choisissant un ou plusieurs critères





Date de la demande Mots-Clefs Adresse postale Equipe Interéssée Date de publication
03/10/2017
Stability of SODIUM THIOSULFATE between 15 and 30mg/ml in 0.9% sodium chloride in polyolefine infusion bags over 24 hours. Surgeons want to administer sodium thiosulfate as a nephroprotector in the context of hyperthermic intraperitoneal chemotherapy (CHIP) with cisplatin.
Chlorure de sodium 0,9%
Injectable
Polyolefine
Hospices Civils de Lyon - Groupement Hospitalier Sud - URCC RANCHON Florence
165 chemin du grand revoyet
Pierre Benite
FRANCE
Yes
Article Publié
02/10/2017
23/09/2017
Stability study of ETOPOSIDE at concentrations between 0.4 and 2 mg / ml diluted in 0.9% sodium chloride in polyolefin infusion bags over seven days. In order to counteract the shortage of etoposide phosphate (Etopophos®).
Etoposide
Chlorure de sodium 0,9%
Injectable
Polyolefine
University Hospital of Nancy D'Huart Elise
Rue du Morvan
Vandoeuvre
France
Yes
Article Publié
23/09/2017
09/10/2017
The physicians of our hospital usually prescribe a mixture of PHLOROGLUCINOL 120 mg, METOCLOPRAMIDE 30 mg and TRIMEBUTINE 150 mg in 5% dextrose 1000 ml. We are looking for a stability study over 24 hours.
Metoclopramide hydrochloride; Phloroglucinol; Trimebutine
Glucose 5%
Injectable
Hospital LA CHATRE BARBAIRE
40 rue des oiseaux
La CHATRE (36400)
FRANCE
No
09/10/2017
03/10/2017
Stability and degradation products in PARACETAMOL injections vials from BBraun®. Paracetamol injections from BBraun® show sometimes a pink colour. This colour change could be the consequence of a degradation product. The composition in excipient of the BBraun® formulation is: mannitol, citric acid and acetic acid. It could be interesting to have a stability study of this formulation.
Paracetamol
Injectable
Polyolefine
CH VERDUN - Pharmacie COLLINOT
BP 713
VERDUN
France
No
02/10/2017
29/10/2017
Stability of CEFTAZIDIME/AVIBACTAM in Manufacturer’s Glass Vials. Ceftazidime/avibactam 2g/0,5g is reconstituted with 10ml of sterile water. The objectif of this study would be to determine the stability of reconstituted Ceftazidime/avibactam in glass vial over at least 48-hours to allow the reuse of the vial.
Ceftazidime Avibactam
Eau pour préparation injectable
Injectable
Verre
Hôpitaux Universitaires de Strasbourg GILBERT
37 boulevard d'anvers
Strasbourg
France
Yes
Article Publié
17/11/2017
08/12/2017
Stability and compatibility of BUFFERED LIDOCAINE from 2.3mg/mL to 3.5 mg/mL with OCTREOTIDE from 2.8 mg/mL to 8.5 mg/mL to limit the pain associated with the intramuscular injection of octreotide.
Lidocaine hydrochloride; Octreotide acetate
Injectable
Seringue polypropylène
CHU Angers - Pharmacie Briot
4 rue larrey
Angers
France
No
12/12/2017
12/01/2018
Stability study of PERTUZUMAB in polyolefin bags in 250 ml of Nacl 0.9%. Long shelf life would allow preparation in advance and potentially economic gain by using the end of flasks.
Pertuzumab
Chlorure de sodium 0,9%
Injectable
Polyolefine
Institut de Cancérologie de l'Ouest - Site Paul Papin Sorrieul jérémy
15 Rue Boquel
Angers
France
No
14/01/2018
19/01/2018
PEMBROLIZUMAB 25 mg/mL diluted in 0.9% chloride sodium at final concentration 4mg/mL. Storage 2-8°C. Stability up to 72 hours ? Manufacturer limits stability data in these conditions at 24 hours.
Pembrolizumab
Chlorure de sodium 0,9%
Injectable
CH René PLEVEN LEROUX CLAIRE
74 rue Chateaubriand - 22100 DINAN
DINAN
france
Yes
Article Publié
21/01/2018
29/01/2018
Stability study of ECULIZUMAB (Soliris®) 5 mg/mL in 0.9% sodium chloride, 0.45% sodium chloride or 5% glucose in polyolefin bags. Long shelf life would allow preparation in advance and would allow storing a bag for reassign it to another patient if the administration is canceled.
Eculizumab
Chlorure de sodium 0,9%; Glucose 5%
Injectable
Polyolefine
UKC Ljubljana Martin Kastrin
University Medical Centre Ljubljana, Zaloška 7, 1000 Ljubljana
Ljubljana
Slovenia
No
Article Publié
30/01/2018
30/01/2018
For Opioid Free Anesthesia : Stability in solution : 1. LIDOCAINE HYDROCHLORIDE 20 mg/mL diluted in 0.9% sodium chloride in polypropylene syringe, at 28°C. 2. KETAMINE HYDROCHLORIDE 2.5 mg/mL diluted in 0.9% sodium chloride in polypropylene syringe at 28°C. Stability of mixture : 1. Stability and compatibility LIDOCAINE HYDROCHLORIDE 20 mg/mL with KETAMINE HYDROCHLORIDE 2.5 mg/mL in 0.9% sodium chloride in polypropylene syringe. Compatibility: 1. Physical compatibility between DEXMEDETOMIDINE 4 µg/mL and KETAMINE 2.5 mg/mL.
Lidocaine hydrochloride; Ketamine hydrochloride; Dexmedetomidine
Chlorure de sodium 0,9%
Injectable
Seringue polypropylène
Réanimation Polyvalente et Centre de Traitement des Brûlés Hopital de Mercy CHR METZ-THIONVILLE Dr Damien BARRAUD
1, allée du château - cs 45001
57085 Metz - Cedex 03
France
Yes
Article Publié
02/03/2018
02/02/2018
Stability of NATALIZUMAB: a) opened vial (7days, 14 days, 1 month) b) prepared natalizumab in 100 ml NaCl piggy bag polyethylen (BAxter) (1day, 7 days, 14 days, 1 month)
Natalizumab
Chlorure de sodium 0,9%
Injectable
Polyéthylène
General hospital Celje Jure Bracun
Oblakova cesta 5a
Celje
Slovenia
No
02/02/2018
21/02/2018
Stability study of DINUTUXIMAB BETA solution. Concentrations : 0.05 mg/mL and 0.5 mg/mL in 100 mL 0.9% sodium chloride in polyolefin bags Duration : 72 hours These data would allow preparing in advance.
pharmacist UMCL Tina Benedejčič
Zaloska 7
Ljubljana
Slovenia
No
02/03/2018
03/05/2018
Stability study of a mixture : METOCLOPRAMIDE 0.04-0.12 mg/mL + NEOSTIGMINE 2-6µg/mL diluted in 250 ml NaCl 0,9% over 1-2 h.
Metoclopramide hydrochloride; Neostigmine methylsulfate
Chlorure de sodium 0,9%
Injectable
marienhospital stuttgart pharmacy reistle barbara
böheimstr 37
Stuttgart
Germany
No
07/05/2018
18/05/2018
Stability study : SUFENTANIL 0.01 mg/2mL with ROPIVACAIN HYDROCHLORIDE 2mg/mL 10mL and TRIAMCINOLON ACETONIDE 10 mg/mL suspension for injection. Administration : epidural injection Use : treatment of intervertebral disc damage
Sufentanil citrate; Ropivacain hydrochloride; Triamcinolone acetonide
Injectable
LVR-Klinik Viersen Tobias Todeskino
Horionstr. 2
41749 Viersen
Deutschland
No
25/05/2018
07/06/2018
Stability Study of VEDOLIZUMAB in 250ml NaCl 0,9% Polyolefinbag over 72h, 7d, 14d. Storage 2-8°C
Vedolizumab
Chlorure de sodium 0,9%
Injectable
Polyolefine
Pharmacy Grillparzer Apotheke
Einsteinstraße 127
81675 Munich
Germany
No
11/06/2018
11/07/2018
Stability AFLIBERCEPT for intravitreal administration in prefilled syringes.
Aflibercept
Seringue polypropylène
Hospital Pharmacist Emilio Campos Dávila
Hospital SAS La Línea. Servicio de Farmacia. c/Ronda Norte esquina Gabriel Miró 108. CP 11300.
La Línea de la Concepción
Spain
No
02/08/2018
03/09/2018
Stability studies : 1. PIPERACILLIN/TAZOBACTAM at 40mg/5mg/mL in dextrose 5% in polypropylene syringes. 2. GENTAMICIN SULFATE at 1 mg/mL in sodium chloride 0.9% in polypropylene syringes. 3. AMIKACIN SULFATE at 5 mg/mL in dextrose 5% in polypropylene syringes. 4. CAFFEINE CITRATE at 5 and 10 mg/mL in dextrose 5% in polypropylene syringes. 5. HEPARIN SODIUM at 0.5 Units/mL in sodium chloride 0.9% and in sodium chloride 0.45% in polypropylene syringes. 6. CEFTAZIDIME at 20mg/mL in dextrose 5% in polypropylene syringes.
Amikacin sulfate; Ceftazidime; Gentamicin sulfate; Heparin sodium; Piperacillin sodium / tazobactam; Caffeine citrate
Chlorure de sodium 0,9%; Glucose 5%; Chlorure de sodium 0,45%
Injectable
Seringue polypropylène
NICU Pharmacist at Kaplan Medical Center Hospital Shay Teitlboim
Loa Haary 45
Gedera
ISRAEL
No
10/09/2018
05/09/2018
Stability studies of ACICLOVIR SODIUM at - 5 mg/mL in sodium chloride 0.9% in polypropylene syringes. - at different concentrations up to 5 mg/mL in polyolefin bags.
Aciclovir sodium
Chlorure de sodium 0,9%
Injectable
Polyolefine; Seringue polypropylène
Lead Pharmacist Aseptic Services Russell Dodd
University Hospitals of Morecambe Bay NHS Trust
Lancaster
England, United Kingdom
No
10/09/2018
17/09/2018
Stability study for intraocular use: VANCOMYCIN 2 mg/mL and 10 mg/mL in balanced salt solution (BSS solution®) in polypropylene syringe.
Vancomycin hydrochloride
BSS solution®
Injectable
Seringue polypropylène
St John of God Hospital Subiaco Michelle Fall
12 Salvado Rd
Subiaco
Australia
No
24/09/2018
24/09/2018
Stability study for intraocular use: AMIKACIN 4 mg/mL in balanced salt solution (BSS solution®) in polypropylene syringe.
Amikacin sulfate
BSS solution®
Collyre
Seringue polypropylène
St John of God Hospital Subiaco Michelle Fall
12 Salvado Rd
Subiaco
Australia
No
24/09/2018
21/09/2018
Stability studies : VEDOLIZUMAB, TOCILIZUMAB, ABATACEPT, PEMBROLIZUMAB.
Vedolizumab; Pembrolizumab
Injectable
Polyolefine
HOPITAUX PRIVES DE METZ PONSEELE MAGDALENA
2 RUE BELLE ISLE
METZ
FRANCE
No
24/09/2018
24/09/2018
Stability study for intraocular use: GENTAMICIN 0.8 mg/mL and 1 mg/mL in balanced salt solution (BSS solution®) in polypropylene syringe.
Gentamicin sulfate
BSS solution®
Seringue polypropylène
St John of God Hospital Subiaco Michelle Fall
12 Salvado Rd
Subiaco
Australia
No
24/09/2018
24/09/2018
Stability study for intraocular use: CEFTAZIDIME 22.5 mg/mL in balanced salt solution (BSS solution®) in polypropylene syringe.
Ceftazidime
BSS solution®
Collyre
Seringue polypropylène
St John of God Hospital Subiaco Michelle Fall
12 Salvado Rd
Subiaco
Australia
No
24/09/2018
24/09/2018
Stability study for intraocular use: VORICONAZOLE 1 mg/mL in balanced salt solution (BSS solution®) in polypropylene syringe.
Voriconazole
BSS solution®
Collyre
Seringue polypropylène
St John of God Hospital Subiaco Michelle Fall
12 Salvado Rd
Subiaco
Australia
No
24/09/2018
24/09/2018
Stability study for intraocular use: AMPHOTERICIN 0.05 mg/mL in balanced salt solution (BSS solution®) in polypropylene syringe.
Amphotericin B
BSS solution®
Collyre
Seringue polypropylène
St John of God Hospital Subiaco Michelle Fall
12 Salvado Rd
Subiaco
Australia
No
24/09/2018
21/11/2018
Stability studies on : - DARATUMUMAB infusions at concentrations between 0.5 and 4 mg/mL, diluted in NaCl 0.9%, in polyolefin bags. - DARATUMUMAB subcutaneous 1800 mg, in polypropylene syringes.
Daratumumab
Chlorure de sodium 0,9%
Injectable
Polyolefine; Seringue polypropylène
CHRU Nancy Lider Pauline
CHRU Nancy - Hôpital Brabois Adultes - Service Pharmacie - 5 rue du Morvan
Vandoeuvre-lès-Nancy
France
No
Article Publié
26/11/2018
04/12/2018
Stability study of OCTREOTIDE at 3.75 µg/mL in elastomer( 900 µg in 240 mL of 0.9% sodium chloride). Indication : occlusion on peritoneal carcinomatosis.
Octreotide acetate
Chlorure de sodium 0,9%
Injectable
Texte introuvable (536, )
GH Diaconesses Croix saint simon Capucine Devaux
125 rue avron
paris
France
No
11/12/2018
07/01/2019
Desearía mas información sobre la estabilidad extendida de las soluciones de trióxido de arsénico
Centro de Mezclas - Hospital Pediátrico Humberto Notti Hector Cruceño
Bra de los Andes 2602
San Jose
Argentina
No
Article Publié
21/01/2019
Stability study on PEMBROLIZUMAB at 2 mg/mL diluted in 0.9%NaCl in polyolefin bag for 1 month.
Pembrolizumab
Chlorure de sodium 0,9%
Injectable
Polyolefine
CHU DIJON PERNOT Corinne
14 rue gaffarel 21000 DIJON
DIJON
FRANCE
No
Article Publié
06/02/2019
21/01/2019
Stability study on DARATUMUMAB infusion between 0.5 and 4mg/mL in 0.9% NaCl, in polyolefin bag.
Daratumumab
Chlorure de sodium 0,9%
Injectable
Polyolefine
CHU DIJON PERNOT Corinne
14 rue gaffarel 21000 DIJON
DIJON
FRANCE
No
04/02/2019
11/03/2019
Stability studies of CYTARABINE : - after dilution in 5 % dextrose, 0.9% sodium chloride or glucose with sodium chloride. - for the unused vial after reconstitution.
Cytarabine
Chlorure de sodium 0,9%; Glucose 5%
Injectable
Verre; Polyolefine
Solvent Dr Hussein
1st abd elhamid barakat BAHEST EL badayiah CORNICHE EL NILE EL SAHEL Cairo Egypt
Cairo
Egypt
No
01/04/2019
27/03/2019
Stability study of : - METHOTREXATE at 1.5 mg/mL - CYTARABINE at 3.75 mg/mL - HYDROCORTISONE HEMISUCCINATE at 2.5 mg/mL for spinal injection.
Cytarabine; Methotrexate sodium; Hydrocortisone sodium succinate
Injectable
Seringue polypropylène
Centre hospitalier d'Arras DANOS
3 Boulevard Besnier
62022 Arras Cedex
France
No
01/04/2019
10/01/2024
Compatibility data of PHOCYTAN (Disodium glucose-1-phosphate tetrahydrate) with others drugs.
Disodium glucose-1-phosphate tetrahydrate
CHU Grenoble alpes Site Voiron Brulebois Aurélie
34 bd jacques Chirac
Voiron
France
No
28/06/2019
Stability study of a mixture levofolinate disodium and fluorouracil in 0.9% sodium chloride infusion bags ( 100 mL)
Fluorouracil; Levofolinate disodium
Chlorure de sodium 0,9%
Polyclinique de Gentilly Alfonsi
2, rue Marie Marvingt
NANCY
France
No
10/07/2019
02/07/2019
Compatibility tests between drugs and balanced infusions solutions as Ringer-acetat.
Pharmacist at a regional drug inforamtion centre in Norway Terje Nilsen
Sykehusveien 20
Tromsø
Norway
No
10/07/2019
30/09/2019
Stability of CEFTAZIDIME/AVIBACTAM (ZAVICEFTA or AVYCAZ) in elastomeric pumps.
Ceftazidime Avibactam
Injectable
Texte introuvable (536, )
Uppsala university hospital Mattias Paulsson
Entrance 13
Uppsala
Sweden
Yes
Article Publié
03/10/2019
06/03/2020
Stability study of a mixture : METAMIZOLE + TRAMADOL + DIMENHYDRATE in 0.9 % sodium chloride.
Tramadol hydrochloride; Dimenhydrinate; Metamizol sodium
Chlorure de sodium 0,9%
Injectable
nn Anneke Maiworm
Apotheke des Universitätsklinikums Düsseldorf
Düsseldorf
Deutschland
No
23/03/2020
22/11/2019
Stability of morphine HCl (2mg/ml) + DHB (0.08mg/ml) + NaCl 0.9% syringe Stability of morphine HCl (2mg/ml) + ketamine (3.3 mg/ml) + NaCl 0.9% syringe Stability of piritramide 2 mg/ml + NaCl 0.9% syringe
Droperidol; Morphine hydrochloride; Ketamine hydrochloride; Piritramide
Chlorure de sodium 0,9%
Injectable
Seringue polypropylène
Clinique Saint Luc bouge Anrys
Rue Saint-Luc, 1
Bouge
Belgique
No
06/12/2019
11/11/2019
Stability of Clarithromycin 1% for eye drops.
Collyre
Pharmacist Julia Parts
Spitalstrasse
Luzern
Schweiz
No
06/12/2019
24/10/2019
Stability study of ARSENIC TRIOXIDE at concentrations between 0.2 and 0.1 mg/mL diluted in 0.9% sodium chloride or 5% dextrose, in polyolefine or PVC infusion bags over five days.
Arsenic trioxyde
Chlorure de sodium 0,9%; Glucose 5%
Injectable
Polyvinyl chlorure; Polyolefine
Hosp Pediatrico Humberto Notti Hector Cruceño
Bandera de los Andes 2601
San Jose
Argentina
No
Article Publié
06/11/2019
07/02/2020
Stability study of a mixture : morphine, droperidol and ketamine.
Droperidol; Morphine hydrochloride; Ketamine hydrochloride
Injectable
CH PIERRE OUDOT PONT
38300
BOURGOIN JALLIEU
FRANCE
No
26/02/2020
08/05/2020
Stability studies for oral solutions of : - morphine hydrochloride [0.4-1 mg/mL] - methadone hydrochloride [0.4-1 mg/mL]
Solution buvable
CENTRE HOSPITALIER LUXEMBOURG ISABELLE LAROSCHE
4 RUE BARBLE
1210 Luxemnbourg
LUXEMBOURG
No
15/05/2020
28/05/2020
Stability study of PEMBROLIZUMAB
Pembrolizumab
CH François Quesnay KANE
02 Boulevard Sully
Mantes La Jolie (78200)
FRANCE
No
Article Publié
30/05/2020
29/06/2020
Stability study of doxycycline eye drops at 2.5 and 0.25%.
Doxycycline hyclate
Collyre
Verre
Pharmacie laboratoire preparation magistrale  Von roten
1926
Fully
Suisse
No
26/07/2020
21/09/2020
Stability study of daratumumab 120 mg/mL in polypropylene syringes.
Daratumumab
Chlorure de sodium 0,9%
Injectable
Seringue polypropylène
Klinische Farmacie Zaans Medisch Centrum Sandra Wolf-Hoogendoorn
Koningin Julianaplein 34, 1509 HS
Zaandam
Netherlands
No
Article Publié
22/09/2020
08/01/2021
morfina +alizapride in elastomero
Ospedale Cardinal Massaia - Asti Valentina Tagini
Corso Dante Alighieri, 202, 14100 Asti AT
Asti
Italia
No
12/01/2021
29/01/2021
Stability study of PERTUZUMAB (PERJETA) in 0.9% sodium chloride in polyolefin bags. Long shelf life would allow storing a bag for reassign it to another patient if the administration is canceled.
Pertuzumab
Chlorure de sodium 0,9%
Injectable
Polyolefine
Hôpitaux Civils de Colmar BOURBON Johan
68000
Colmar
France
No
29/01/2021
17/03/2021
Stability study of Sulfamethoxazole/trimethoprim (Bactrim®) at 3.2/0.64 mg/mL and 4,8/0,96 mg/mL in 5% glucose and Ringer lactate and NaCl 0.9% (if possible) in polyolefin bags at ambient temperature. We expect stability data over 12 to 24 h in order to allow continuous administration. These concentrations correspond to 8 ampoules of bactrim 400/80mg/5mL in 1000 mL and 6 ampoules in 500 mL solution bag.
Co-trimoxazole
Chlorure de sodium 0,9%; Glucose 5%; Ringer lactate
Injectable
Polypropylène
Groupe Hospitalier Sud Ile de France (GHSIF) Bruno Cassard
270 avenue Marc jacquet
77 000 MELUN
France
Yes
21/03/2021
04/04/2021
Compatibilitu study of a mixture methotrexate with dexamethasone for intrathecal use.
Dexamethasone sodium phosphate; Methotrexate sodium
Injectable
Seringue polypropylène
Dr. ANGELO SALAS TORRES
Avenida Arenales. Edificio Genova. Departamento 1305
LIMA
PERU
No
08/04/2021
21/07/2021
Stability study of daratumumab for subcutaneous administration : 1800 mg/15 mL in polypropylene syringe
Daratumumab
Injectable
Seringue polypropylène
CH Annecy Genevois ZECCHINI PRINA Céline
21 route des ilettes
74 370 METZ TESSY
France
No
Article Publié
18/08/2021
24/08/2021
Stability study of TOCILIZUMAB diluted in 0.9% sodium chloride.
Tocilizumab
Chlorure de sodium 0,9%
Injectable
Polyolefine
CHT  ANGAPIN Annabelle
BP J5 98849 NOUMEA Cedex – Nouvelle-Calédonie
NOUMEA
Nouvelle-Calédonie
No
Article Publié
07/09/2021
25/10/2021
Stability study of vancomycin 10 mg/mL in Balanced Salt Solution and ceftazidime 22.5 mg/mL in normal saline at -25°C in polypropylene syringe for intravitreal injection.
Vancomycin hydrochloride; Ceftazidime
Chlorure de sodium 0,9%; BSS solution®
Collyre
Seringue polypropylène
Aved Heather Arnott
44 Richmond St. W., Unit 202
Oshawa, Ontario
Canada
No
18/02/2022
16/02/2022
Stability study of Methylprednisolone sodium succinate reconstitued at 2-8°C and room temperature.
Methylprednisolone sodium succinate
Eau pour préparation injectable
Injectable
Verre
Solido parenteral metilprednisolona succinato
santo domingo
Santo Domingo
Ecuador
No
18/02/2022
20/04/2022
Stability study : Idarubicin 1mg/mL solution for injection (e.g. not the powder formulation) Pfizer and Accord brands as starting material, with comparison of the two. Solvant of dilution : Sodium Chloride 0.9% Concentration : 0.05 mg/ml (diluted) to undiluted 1mg/mL Final container = Polypropylene syringe and Polyolefin bag Storage at room temperature and refrigerated, protected from light, at 24 hours, 48 hours, 7 days and 28 days. Study to comply with NHS guidelines: A Standard Protocol for Deriving and Assessment of Stability https://www.sps.nhs.uk/wp-content/uploads/2013/12/Stability-part-1-small-molecules-5th-Ed-Sept-19.pdf
Idarubicin hydrochloride
Chlorure de sodium 0,9%
Injectable
Polyolefine; Seringue polypropylène
Great Ormond Street Hospital Elin Vikman
Great Ormond Street
London
United Kingdom
No
21/04/2022
02/05/2022
Stability study of PEMBROLIZUMAB in 0.9% NaCl in polyolefin bags for advance preparation.
Pembrolizumab
Chlorure de sodium 0,9%
Injectable
Polyolefine
chu nimes Carbasse
place du professeur Robert Debre
NIMES
FRANCE
No
16/05/2022
16/05/2022
Stability study of amphotericin B at 50 µg/mL in water for injection, stored in polypropylene syringe at room temperature (20-25°C), 2-8°C and -20°C for intravitreal injection.
Amphotericin B
Eau pour préparation injectable
Injectable
Seringue polypropylène
CHRU NANCY MORICE
Allée du Morvan
VANDOEUVRE-LES-NANCY
FRANCE
No
19/05/2022
19/05/2022
Compatibility test of magnesium sulphate and monosodium phosphate.
Hospital Universitario Vall Hebron Inés Jiménez Lozano
Passeig Vall Hebron 119-129
Barcelona
España
Yes
03/06/2022
28/12/2023
Stability study of NAB-PACLITAXEL in glass vial and in polyolefin bag for extended data.
Paclitaxel albumin
Injectable
Polyolefine; Flacon entamé
CHU de nimes Carbasse
place du professeur robert debre
Nimes
France
No
18/01/2024
12/07/2022
Grafalon® (Neovii Biotech GmbH) in NaCl 0,9% bag PVC-free, stored at 2-8 °C, protected from light for 7 days. Concentration : 20 mg/7 mL
Chlorure de sodium 0,9%
Injectable
Polyolefine
Campus Kiel Holste
Arnold-Heller-Str. 3 | Haus V.11 | 24105 Kiel
Kiel
Allemagne
No
12/07/2022
17/11/2022
Stability study : Avelumab between 2.5-3mg/ml in 0.9% sodium chloride in infusion bags
Avelumab
Chlorure de sodium 0,9%
Injectable
Polypropylène; Polyéthylène; Polyolefine
ICO Angers Jeremy Sorrieul
15 rue andre boquel
Avrille
France
No
17/11/2022
17/11/2022
Stability study : Trastuzumab Emtansine between 0.5-1.5 mg/ml in infusion bags, diluted in 0.9% NaCl.
Chlorure de sodium 0,9%
Injectable
Polypropylène; Polyéthylène; Polyolefine
ICO Angers Jeremy Sorrieul
15 rue andre boquel
Avrille
France
No
17/11/2022
17/11/2022
Stability study : Trastuzumab Deruxetan between 1.5 et 4.5 mg/ml in infusion bags, diluted in D5W.
Trastuzumab deruxtecan
Glucose 5%
Injectable
ICO Angers Jeremy Sorrieul
15 rue andre boquel
Avrille
France
No
23/11/2023
23/03/2023
Stability studies : - Trastuzumab-Emtansine : 20 mg/mL with water for injection in glass vial between 2-8°C or at room temperature during 7 days. - Trastuzumab-Deruxtecan : 20 mg/mL ith water for injection in glass vial between 2-8°C or at room temperature during 7 days. - Cyclophosphamide : 20 mg/mL with 0.9% NaCl in glass vial between 2-8°C or at room temperature during 7 days.
Cyclophosphamide; Trastuzumab deruxtecan
Eau pour préparation injectable; Chlorure de sodium 0,9%
Injectable
Verre
Hôpital Privé Jean Mermoz PACE Jean-Baptiste
55 avenue Mermoz
Lyon
France
No
24/03/2023
08/06/2023
Stability study : Alteplase 0.25 mg/mL in 0.9% sodium chloride for 25 hours at room temperature (administered via continuous infusion pump in a PVC containing or DHEP containing bag of sodium chloride). Indication : Alteplase as a continuous low dose infusion over 25 hours (repeated for up to 5 days) may be used for the management of prosthetic valve thrombosis as an alternative to valve surgery in patients without contraindications to fibrinolysis.
Alteplase
Chlorure de sodium 0,9%
Injectable
Polyvinyl chlorure; Polyolefine
John Hunter Hospital,  Carly Kippist
Locked Bag 1, Hunter Region Mail Centre
New Lambton
Australia
No
30/06/2023
21/11/2023
Stability study : N-acétylcystéine at 80-160-200 mg/mL in 0.9% sodium chloride, in polypropylene syringes.
N-acetylcysteine
Chlorure de sodium 0,9%
Injectable
Seringue polypropylène
CHU Grenoble Alpes Léa Liaigre
Boulevard de la Chantourne
La Tronche
FRANCE
No
21/11/2023

  Mentions Légales